| Revenue growth | FY26 net sales reached ₹502.55 Cr, a 11.23% YoY increase. |
|---|---|
| Margins | Profit before exceptional items grew faster (25.47%) than sales (11.23%). |
| Demand visibility | Positive outlook for the new year across core and new categories. |
| Management confidence | High; confident in demand environment and unique value propositions. |
Growth
FY26 Net Sales grew 11.23%; Q4 FY26 grew 10.6%. FY26 Profit before exceptional items rose 25.47%.
Outlook
New sanitary pad plant starting May 2026; targeting 100K chemists by Sept FY27; relaunching 'Relief' brand.
Risks
COGS inflation due to Middle East conflicts affecting crude prices; one-time legal and labor code charges.
Earnings Call filed with NSE, NSE: AMRUTANJAN. Summary written with AI assistance from the document.
Amrutanjan Health Care Ltd: key numbers
- Share price
- ₹506.35
- Market cap
- ₹1,464 Cr
- Revenue (annual)
- ₹502.6 Cr
- Net profit (annual)
- ₹57.92 Cr
- P/E (TTM)
- 27.1×Sector 50.4×
- Promoter holding
- 46.52%+0.00% QoQ
- FII holding
- 2.44%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Amrutanjan Health Care Ltd
All →Amrutanjan Health Care Annual General Meeting
Amrutanjan Health Care Limited held its 89th AGM on September 23, 2026. The meeting transacted business including the adoption of accounts, dividend declaration, and director re-appointment.
Amrutanjan Health Care Investor Presentation: Key Takeaways
Amrutanjan reported 9.48% revenue growth in Q1 FY27, driven by Women's Hygiene (21%) and Beverages (11.34%). Profitability was hit by a one-time INR 2.02 Cr lease rent provision.
- Call
- Guides 10% growth
Amrutanjan Health Care Q1 FY27 Results: Net Profit ₹4.4 Cr, Down 47.0% YoY
Amrutanjan Health Care Ltd reported revenue from operations of ₹103 Cr (+9.6% YoY) and net profit of ₹4.4 Cr (-47.0% YoY) for Q1 FY27.
- Key figure
- Net profit ₹4.4 Cr · -47.0% YoY
Amrutanjan Health Care Earnings Call: Key Takeaways
Amrutanjan reported 11.23% revenue growth for FY26 with significant 37.2% jump in Q4 profit before exceptional items. Strategy focuses on power brands, distribution expansion, and digitization.
Amrutanjan Health Care Q4 FY26 Results: Net Profit ₹16.2 Cr, Up 6.6% YoY
Amrutanjan Health Care Ltd reported revenue from operations of ₹149.8 Cr (+10.6% YoY) and net profit of ₹16.2 Cr (+6.6% YoY) for Q4 FY26.
- Key figure
- Net profit ₹16.2 Cr · +6.6% YoY